Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Emberton

Showing results (321-330 of 474) with videos related to

Pageof 48
Sort By:
Nuclear Medicine Communications|April 28, 2026
18F choline PET/MR to assess clinically significant disease in prostate cancer: correlation with maximum and total cancer core length obtained via template mapping biopsiesAthar Haroon, Ahmad Almuhaideb, Sola Adeleke, et al.
Frontiers in Artificial Intelligence|December 6, 2021
The ReIMAGINE Multimodal Warehouse: Using Artificial Intelligence for Accurate Risk Stratification of Prostate CancerAida Santaolalla, Tim Hulsen, Jenson Davis, et al.
BMJ (Clinical Research Ed.)|November 23, 2006
Self management for men with lower urinary tract symptoms: randomised controlled trialChristian T Brown, Tet Yap, David A Cromwell, et al.
Physics in Medicine and Biology|March 17, 2025
A semi-supervised prototypical network for prostate lesion segmentation from multimodality MRIWen Yan, Yipeng Hu, Qianye Yang, et al.
European Urology Open Science|August 2, 2021
Which Prostate Cancers are Undetected by Multiparametric Magnetic Resonance Imaging in Men with Previous Prostate Biopsy? An Analysis from the PICTURE StudyJoseph M Norris, Lucy A M Simmons, Abi Kanthabalan, et al.
European Urology Open Science|April 24, 2023
Prostate Cancer IRE Study (PRIS): A Randomized Controlled Trial Comparing Focal Therapy to Radical Treatment in Localized Prostate CancerAnna Lantz, Per Nordlund, Ugo Falagario, et al.
BJU International|September 14, 2013
TOOKAD(®) Soluble vascular-targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancerAbdel-Rahmène Azzouzi, Eric Barret, Caroline M Moore, et al.
The Journal of Urology|May 10, 2022
Geographic Variability, Time Trends and Association of Preoperative Magnetic Resonance Imaging with Surgical Outcomes for Elderly United States Men with Prostate Cancer: A Surveillance, Epidemiology, and End Results-Medicare AnalysisAlexander P Cole, Xi Chen, Bjoern J Langbein, et al.
Magnetic Resonance Imaging|January 4, 2020
DWI and PRECISE criteria in men on active surveillance for prostate cancer: A multicentre preliminary experience of different ADC calculationsFrancesco Giganti, Martina Pecoraro, Davide Fierro, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 27, 2020
Investigating the performance of a novel pH and cathepsin B sensitive, stimulus-responsive nanoparticle for optimised sonodynamic therapy in prostate cancerMarym Mohammad Hadi, Heather Nesbitt, Hamzah Masood, et al.
Pageof 48

Showing results (321-330 of 474) with videos related to

Sort By:
Pageof 48
Nuclear Medicine Communications|April 28, 2026
18F choline PET/MR to assess clinically significant disease in prostate cancer: correlation with maximum and total cancer core length obtained via template mapping biopsiesAthar Haroon, Ahmad Almuhaideb, Sola Adeleke, et al.
Frontiers in Artificial Intelligence|December 6, 2021
The ReIMAGINE Multimodal Warehouse: Using Artificial Intelligence for Accurate Risk Stratification of Prostate CancerAida Santaolalla, Tim Hulsen, Jenson Davis, et al.
BMJ (Clinical Research Ed.)|November 23, 2006
Self management for men with lower urinary tract symptoms: randomised controlled trialChristian T Brown, Tet Yap, David A Cromwell, et al.
Physics in Medicine and Biology|March 17, 2025
A semi-supervised prototypical network for prostate lesion segmentation from multimodality MRIWen Yan, Yipeng Hu, Qianye Yang, et al.
European Urology Open Science|August 2, 2021
Which Prostate Cancers are Undetected by Multiparametric Magnetic Resonance Imaging in Men with Previous Prostate Biopsy? An Analysis from the PICTURE StudyJoseph M Norris, Lucy A M Simmons, Abi Kanthabalan, et al.
European Urology Open Science|April 24, 2023
Prostate Cancer IRE Study (PRIS): A Randomized Controlled Trial Comparing Focal Therapy to Radical Treatment in Localized Prostate CancerAnna Lantz, Per Nordlund, Ugo Falagario, et al.
BJU International|September 14, 2013
TOOKAD(®) Soluble vascular-targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancerAbdel-Rahmène Azzouzi, Eric Barret, Caroline M Moore, et al.
The Journal of Urology|May 10, 2022
Geographic Variability, Time Trends and Association of Preoperative Magnetic Resonance Imaging with Surgical Outcomes for Elderly United States Men with Prostate Cancer: A Surveillance, Epidemiology, and End Results-Medicare AnalysisAlexander P Cole, Xi Chen, Bjoern J Langbein, et al.
Magnetic Resonance Imaging|January 4, 2020
DWI and PRECISE criteria in men on active surveillance for prostate cancer: A multicentre preliminary experience of different ADC calculationsFrancesco Giganti, Martina Pecoraro, Davide Fierro, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 27, 2020
Investigating the performance of a novel pH and cathepsin B sensitive, stimulus-responsive nanoparticle for optimised sonodynamic therapy in prostate cancerMarym Mohammad Hadi, Heather Nesbitt, Hamzah Masood, et al.
Pageof 48